Stephan Arni
Overview
Explore the profile of Stephan Arni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Villegas R, Arni S
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38255680
Cytokine adsorption can resolve different complications characteristic of transplantation medicine, such as cytokine storm activation and blood ABO and immune incompatibilities. Cytokine adsorption is also performed for the treatment of...
2.
Ehrsam J, Arni S, Weisskopf M, Nowack M, Inci I
JTCVS Open
. 2023 Oct;
15:497-507.
PMID: 37808017
Objectives: Ischemia-reperfusion injury often coincides with a cytokine storm, which can result in primary graft dysfunction following lung transplantation. Our previous research has demonstrated allograft improvement by cytokine adsorption during...
3.
Ehrsam J, Chen J, Haberecker M, Arni S, Inci I
Transplant Direct
. 2023 Aug;
9(9):e1516.
PMID: 37575952
Methods: Rat single-lung transplantation was performed in 2 groups (n = 8 per group), using Brown-Norway donors and major histocompatibility complex-mismatched Lewis recipients. Recipients of the NAD group received 1000 ...
4.
Ehrsam J, Chen J, Rodriguez Cetina Biefer H, Opitz I, Arni S, Inci I
Antioxidants (Basel)
. 2022 May;
11(5).
PMID: 35624707
Ischemia-reperfusion injury compromises short- and long-term outcomes after lung transplantation. The scarce existing data on NAD suggest effects on hypoxia-induced vasoconstriction, on reactive oxygen species and on tampering inflammation. We...
5.
Jin X, Kaes J, Van Slambrouck J, Inci I, Arni S, Geudens V, et al.
Cells
. 2022 Feb;
11(3).
PMID: 35159289
Lung transplantation improves the outcome and quality of life of patients with end-stage pulmonary disease. However, the procedure is still hampered by the lack of suitable donors, the complexity of...
6.
Arni S, Maeyashiki T, Latshang T, Opitz I, Inci I
Cells
. 2021 Sep;
10(9).
PMID: 34571948
Ex vivo lung perfusion (EVLP) has been implemented to increase the number of donor lungs available for transplantation. The use of K(ATP) channel modulators during EVLP experiments may protect against...
7.
Arni S, Necati C, Maeyashiki T, Opitz I, Inci I
Cells
. 2021 Sep;
10(9).
PMID: 34571898
The quality of marginal donor lungs is clinically assessed with normothermic machine perfusion. Although subnormothermic temperature and perfluorocarbon-based oxygen carriers (PFCOC) have proven favourable for other organ transplants, their beneficial...
8.
Arni S, Maeyashiki T, Opitz I, Inci I
PLoS One
. 2021 Aug;
16(8):e0255155.
PMID: 34339443
Use of normothermic ex vivo lung perfusion (EVLP) was adopted in clinical practice to assess the quality of marginal donor lungs. Subnormothermic perfusion temperatures are in use among other solid...
9.
Arni S, Maeyashiki T, Citak N, Opitz I, Inci I
Cells
. 2021 Apr;
10(4).
PMID: 33805274
Normothermic machine perfusion is clinically used to assess the quality of marginal donor lungs. Although subnormothermic temperatures have proven beneficial for other solid organ transplants, subnormothermia-related benefits of ex vivo...
10.
Inci I, Arni S, Iskender I, Citak N, Rodriguez J, Weisskopf M, et al.
Cells
. 2020 Nov;
9(11).
PMID: 33218154
Background: Ex vivo lung perfusion (EVLP) is a technology that allows the re-evaluation of questionable donor lung before implantation and it has the potential to repair injured donor lungs that...